UBS Group’s Gelteq Ltd GELS Stock Holding History

UBS Group’s Portfolio GELS Stock Details GELS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83	Sell	125 -1,709	-93%	-$1.1K	﹤0.01%	10133
2026 Q1	$1.21K	Buy	+1,834	New	+$1.53K	﹤0.01%	9585
2025 Q4	–	Sell	-952	Closed	-$1.31K	–	11393
2025 Q3	$1.31K	Sell	952 -4,586	-83%	-$7.12K	﹤0.01%	9378
2025 Q2	$9.58K	Sell	5,538 -17,916	-76%	-$29.4K	﹤0.01%	8882
2025 Q1	$24.4K	Buy	23,454 +17,255	+278%	+$32.3K	﹤0.01%	8098
2024 Q4	$14.4K	Buy	+6,199	New	+$15.1K	﹤0.01%	8098

Other funds holding GELS

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group's GELS Position: Q2 2026 in Review

UBS Group reduced its Gelteq Ltd (GELS) stake by 93% in Q2 2026, selling an estimated $1.1K and leaving 125 shares worth $83. The position accounts for ﹤0.01% of the portfolio, ranked #10133.

UBS Group first reported a position in GELS in Q4 2024 and has held it in 6 quarters since. The position peaked at $24.4K in Q1 2025. 6 funds tracked by Wall St. Rank hold GELS as of Q2 2026.

UBS Group held 125 shares of Gelteq Ltd worth $83 as of Q2 2026.
UBS Group sold 1,709 Gelteq Ltd shares in Q2 2026, an estimated $1.1K.
Gelteq Ltd made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10133 holding.
UBS Group first reported a position in Gelteq Ltd in Q4 2024 and has held it in 6 quarters since.
UBS Group's Gelteq Ltd position peaked at $24.4K in Q1 2025.
6 funds tracked by Wall St. Rank held Gelteq Ltd as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.